CD36 and metabolic dysfunction-associated steatohepatitis: Although METTL3-mediated m6A modification may not be involved in the regulation of Cd36 and Ccl2 expression in the pathogenesis of NASH, METTL3-mediated m6A modification may regulate the expression of other genes and other liver processes33, which requires further study.